Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease
This article discusses the role that melatonin may have in the prevention and treatment of Parkinson's disease (PD). In parkinsonian patients circulating melatonin levels are consistently disrupted and the potential therapeutic value of melatonin on sleep disorders in PD was examined in a limit...
Tallennettuna:
Päätekijät: | Santiago Pérez-Lloret (Tekijä), Daniel P. Cardinali (Tekijä) |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
Editorial: Neuroprotection and disease modification in Parkinson's disease: Volume II
Tekijä: Matilde Otero-Losada, et al.
Julkaistu: (2023) -
Editorial: Neuroprotection and Disease Modification in Parkinson's Disease
Tekijä: Matilde Otero-Losada, et al.
Julkaistu: (2021) -
Dual-Task Treadmill Training for the Prevention of Falls in Parkinson's Disease: Rationale and Study Design
Tekijä: Veit Mylius, et al.
Julkaistu: (2022) -
Cytoprotective Effects of Melatonin Against Amitriptyline-Induced Toxicity in Isolated Rat Hepatocytes
Tekijä: Shohreh Taziki, et al.
Julkaistu: (2015) -
Melatonin Therapy in Patients with Alzheimer's Disease
Tekijä: Daniel P. Cardinali, et al.
Julkaistu: (2014)